Indication
Treatment of adult patients with high-grade (HG), Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC)
Loading your page…
Loading your page…
Non-Muscle Invasive Bladder Neoplasms
Marketing Authorisation Holder: Ferring Pharmaceuticals A/S
INN: nadofaragene firadenovec
AI Drug & Interaction Analysis
Free account required
Ask Osler about Adstiladrin: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.